Ochratoxin A(OTA) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Ochratoxin A(OTA) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Mycotoxins diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-147-11. BSA-Ochratoxin A(OTA)
2. Anti-Ochratoxin A(OTA) mouse monoclonal antibody
$2709.00
GMP-SMT-147-21. OVA-Ochratoxin A(OTA)
2. Anti-Ochratoxin A(OTA) mouse monoclonal antibody
$2709.00
GMP-SMT-147-31. BSA-Ochratoxin A(OTA)
2. Anti-Ochratoxin A(OTA) human monoclonal antibody
$2709.00
GMP-SMT-147-41. OVA-Ochratoxin A(OTA)
2. Anti-Ochratoxin A(OTA) human monoclonal antibody
$2709.00
GMP-SMT-147-Ag-1BSA-Ochratoxin A(OTA)$756.00
GMP-SMT-147-Ag-2OVA-Ochratoxin A(OTA)$756.00
GMP-SMT-147-Ab-1Anti-Ochratoxin A(OTA) mouse monoclonal antibody$1953.00
GMP-SMT-147-Ab-2Anti-Ochratoxin A(OTA) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Ochratoxin A(OTA)

Cat No.GMP-SMT-147-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Ochratoxin A(OTA) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Ochratoxin A(OTA) had been validated with our anti-Hapten antibody Anti-Ochratoxin A(OTA) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Ochratoxin A(OTA)

Cat No.GMP-SMT-147-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Ochratoxin A(OTA) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Ochratoxin A(OTA) had been validated with our anti-Hapten antibody Anti-Ochratoxin A(OTA) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Ochratoxin A(OTA) mouse monoclonal antibody

Cat No.GMP-SMT-147-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Ochratoxin A(OTA) had been validated with our hapten hapten-carrier conjugates BSA-Ochratoxin A(OTA) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Ochratoxin A(OTA) human monoclonal antibody

Cat No.GMP-SMT-147-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.1-0.2
Products descriptionThe anti-Hapten antibody against hapten Ochratoxin A(OTA) had been validated with our hapten hapten-carrier conjugates BSA-Ochratoxin A(OTA) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. What is Ochratoxin A (OTA), and what is its role in Mycotoxins?

    Ochratoxin A (OTA) stands as a mycotoxin of paramount concern, recognized for its frequent occurrence in agricultural commodities, and its pivotal role in mycotoxin research is indisputable.

    (Serial Number 1) OTA, classified as a low molecular weight secondary metabolite, is produced predominantly by molds of the Aspergillus and Penicillium genera. These molds frequently colonize various food and feed commodities, making OTA contamination a widespread issue in the agricultural industry. The toxin's notoriety arises from its severe health implications for both humans and animals.

    OTA's primary action mechanism is its nephrotoxicity, posing a significant risk to renal health. Furthermore, OTA is classified as a possible human carcinogen, with specific associations found between OTA exposure and the development of renal carcinoma. In addition to its carcinogenic potential, OTA has been shown to exert immunotoxic, teratogenic, and neurotoxic effects. Regulatory bodies across the globe have therefore established stringent guidelines and maximum permissible levels for OTA in food and feed products to protect public health.

    Ochratoxin A plays an instrumental role in the context of mycotoxins, as it is a representative member of a diverse group of fungal toxins that commonly contaminate agricultural commodities. The assessment and regulation of OTA levels are not isolated efforts but serve as integral components of a broader strategy to address mycotoxin contamination, a pervasive and enduring concern in the food and feed industry.

    2. Why measure Ochratoxin A (OTA)?

    The quantification of Ochratoxin A (OTA) is indispensable for an array of compelling reasons that encompass diverse facets of food safety, regulatory compliance, consumer trust, animal welfare, and economic stability.

    (Serial Number 2) a. Food Safety and Health Preservation: OTA's reputation as a potent mycotoxin with documented adverse health effects underscores the paramount importance of its accurate quantification. OTA is predominantly nephrotoxic, posing significant risks to kidney health. Additionally, it is classified as a potential carcinogen, particularly linked to renal carcinoma. To protect public health, precise OTA quantification in food and feed products is imperative, ensuring that consumers are shielded from unsafe levels of this toxin.

    b. Regulatory Compliance: Regulatory agencies worldwide have established rigorous standards and maximum allowable limits for OTA in food and feed commodities. Complying with these regulations is not solely a legal necessity but also a fundamental step in upholding the safety and quality of agricultural products. Failure to meet these standards can result in legal consequences and tarnished industry reputations.

    c. Consumer Trust and Confidence: Rigorous monitoring and control of OTA levels in food and agricultural products significantly bolster consumer confidence. When consumers are assured that the products they purchase are free from harmful mycotoxin contamination, it enhances their trust in the industry, underpinning the integrity of the food supply chain.

    d. Animal Health and Welfare: OTA's impact extends beyond human health to animal welfare. When present in animal feed, OTA can exert detrimental effects on livestock. Monitoring OTA levels is, therefore, not only crucial for safeguarding animal health but also for preventing the transmission of OTA through the food chain, ultimately ensuring the well-being of both animals and consumers.

    e. Economic Considerations: Mycotoxin contamination, including OTA, can result in substantial economic losses for the food and agriculture sector. Products contaminated with mycotoxins may be rejected or recalled, leading to financial setbacks for producers and manufacturers. Accurate OTA measurement is instrumental in preventing the introduction of contaminated products into the market, mitigating economic consequences.

    In summation, the quantification of Ochratoxin A (OTA) transcends mere analytical necessity; it assumes the role of a linchpin in ensuring food safety, regulatory adherence, consumer confidence, animal welfare, and economic sustainability within the food and agriculture industry. Biopharmaceutical companies that offer anti-OTA antibodies and small molecules competitive antigens play an integral part in facilitating precise and dependable OTA detection, thereby contributing to the overall safety and reliability of the food supply chain.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.